INHIBITION OF NITRIC-OXIDE SYNTHESIS BY N-G-NITRO-L-ARGININE METHYL-ESTER (L-NAME) - REQUIREMENT FOR BIOACTIVATION TO THE FREE ACID, N-G-NITRO-L-ARGININE
S. Pfeiffer et al., INHIBITION OF NITRIC-OXIDE SYNTHESIS BY N-G-NITRO-L-ARGININE METHYL-ESTER (L-NAME) - REQUIREMENT FOR BIOACTIVATION TO THE FREE ACID, N-G-NITRO-L-ARGININE, British Journal of Pharmacology, 118(6), 1996, pp. 1433-1440
1 The L-arginine derivatives N-G-nitro-L-arginine (L-NOARG) and NG-nit
ro-L-arginine methyl ester (L-NAME) have been widely used to inhibit c
onstitutive NO synthase (NOS) in different biological systems. This wo
rk was carried out to investigate whether L-NAME is a direct inhibitor
of NOS or requires preceding hydrolytic bioactivation to L-NOARG for
inhibition of the enzyme. 2 A bolus of L-NAME and L-NOARG (0.25 mu mol
) increased coronary perfusion pressure of rat isolated hearts to the
same extent (21+/-0.8 mmHg; n=5), but the effect developed more rapidl
y following addition of L-NOARG than L-NAME (mean half-time: 0.7 vs. 4
.2 min). The time-dependent onset of the inhibitory effect of L-NAME w
as paralleled by the appearance of L-NOARG in the coronary effluent. 3
Freshly dissolved L-NAME was a 50 fold less potent inhibitor of purif
ied brain NOS (mean IC50 = 70 mu M) than L-NOARG (IC50 = 1.4 mu M), bu
t the apparent inhibitory potency of L-NAME approached that of L-NOARG
upon prolonged incubation at neutral or alkaline pH. H.p.l.c. analyse
s revealed that NOS inhibition by L-NAME closely correlated with hydro
lysis of the drug to L-NOARG. 4 Freshly dissolved L-NAME contained 2%
of L-NOARG and was hydrolyzed with a half-life of 365+/-11.2 min in bu
ffer (pH 7.4), 207+/-1.7 min in human plasma, and 29+/-2.2 min in whol
e blood (n = 3 in each case). When L-NAME was preincubated in plasma o
r buffer, inhibition of NOS was proportional to formation of L-NOARG,
but in blood the inhibition was much less than expected from the rates
of L-NAME hydrolysis. This was explained by accumulation of L-NOARG i
n blood cells. 5 These results suggest that L-NAME represents a prodru
g lacking NOS inhibitory activity unless it is hydrolyzed to L-NOARG.
Bioactivation of L-NAME proceeds at moderate rates in physiological bu
ffers, but is markedly accelerated in tissues such as blood or vascula
r endothelium.